Primary Sjögren's syndrome and the risk of acute myocardial infarction: A nationwide study

Acta Cardiologica Sinica

Volumn 29, Issue 2, 2013, Pages 124-131

  Chiang, Chia Hung ^a,b,c   Liu, Chia Jen ^b,c   Chen, Ping Jen ^d   Leu, Hsin Bang ^b,c   Hsu, Chien Yi ^b,c   Huang, Po Hsun ^b,c   Chen, Tzeng Ji ^b   Lin, Shing Jong ^b,c   Chen, Jaw Wen ^b,c   Chan, Wan Leong ^b  

^a Zhudong Veterans Hospital   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Acute myocardial infarction; Atherosclerosis; Primary Sj gren's syndrome

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SJOEGREN SYNDROME; TAIWAN;

EID: 84878333512     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Fox RI. Sjogren's syndrome. Lancet 2005;366: 321-31.
2. Ramos-Casals M, Tzioufas AG, Font J. Primary sjogren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis 2005;64: 347-54.
3. Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the united states. Part I. Arthritis Rheum 2008;58: 15-25.
4. Zhang NZ, Shi CS, Yao QP, et al. Prevalence of primary sjogren's syndrome in china. J Rheumatol 1995;22: 659-61.
5. Sherer Y, Zinger H, Shoenfeld Y. Atherosclerosis in systemic lupus erythematosus. Autoimmunity 2010;43: 98-102.
6. Nossent J, Cikes N, Kiss E, et al. Current causes of death in systemic lupus erythematosus in europe, 2000-2004: relation to disease activity and damage accrual. Lupus 2007;16: 309-17.
7. Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 2005;35: 8-17.
8. Lodde BM, Sankar V, Kok MR, et al. Serum lipid levels in sjogren's syndrome. Rheumatology (Oxford) 2006;45: 481-4.
9. Ramos-Casals M, Brito-Zerón P, Sisó A, et al. High prevalence of serum metabolic alterations in primary sjogren's syndrome: influence on clinical and immunological expression. J Rheumatol 2007;34: 754-61.
10. Pérez-De-Lis M, Akasbi M, Sisó A, et al. Cardiovascular risk factors in primary sjogren's syndrome: a case-control study in 624 patients. Lupus 2010;19: 941-8.
11. Vaudo G, Bocci EB, Shoenfeld Y, et al. Precocious intima-media thickening in patients with primary sjogren's syndrome. Arthritis Rheum 2005;52: 3890-7.
12. Lin HP, Deng CY, Chou P. Diagnosis and treatment delay among pulmonary tuberculosis patients identified using the taiwan reporting enquiry system, 2002-2006. BMC Public Health 2009; 9:55.
13. Weng MY, Huang YT, Liu MF, et al. Incidence of cancer in a nationwide population cohort of 7852 patients with primary sjogren's syndrome in taiwan. Ann Rheum Dis 2012;71: 524-7.
14. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for sjogren's syndrome: a revised version of the european criteria proposed by the american-european consensus group. Ann Rheum Dis 2002;61: 554-8.
15. Chiang CH, Liu CJ, Chen PJ, et al. Hip fracture and risk of acute myocardial infarction: a nationwide study. J Bone Miner Res 2013;28: 404-11.
16. Shoenfeld Y, Gerli R, Doria A, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005;112: 3337-47.
17. Mak A, Liu Y, Ho RC. Endothelium-dependent but not endothelium- independent flow-mediated dilation is significantly reduced in patients with systemic lupus erythematosus without vascular events: a metaanalysis and metaregression. J Rheumatol 2011;38: 1296-303.
18. Vaudo G, Marchesi S, Gerli R, et al. Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 2004;63: 31-5.
19. Munzel T, Sinning C, Post F, et al. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann Med 2008;40: 180-96.
20. Gerli R, Vaudo G, Bocci EB, et al. Functional impairment of the arterial wall in primary sjogren's syndrome: combined action of immunologic and inflammatory factors. Arthritis Care Res 2010; 62: 712-8.
21. Diehm C, Allenberg JR, Pittrow D, et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009;120: 2053-61.
22. Rachapalli SM, Kiely PD, Bourke BE. Prevalence of abnormal ankle brachial index in patients with primary sjogren's syndrome. Clin Rheumatol 2009;28: 587-90.
23. Theander E, Manthorpe R, Jacobsson LT. Mortality and causes of death in primary sjogren's syndrome: a prospective cohort study. Arthritis Rheum 2004;50: 1262-9.
24. Lin HC, Lin YJ, Liu TC, et al. Urbanization and stroke prevalence in Taiwan: analysis of a nationwide survey. J Urban Health 2007; 84: 604-14.
25. Chen HJ, Bai CH, Yeh WT, et al. Influence of metabolic syndrome and general obesity on the risk of ischemic stroke. Stroke 2006; 37: 1060-4.
26. Kiyota Y, Schneeweiss S, Glynn RJ, et al. Accuracy of medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J 2004;148: 99-104.